Pragmatic Trial of Messaging to Providers About Treatment of Heart Failure

NACompletedINTERVENTIONAL
Enrollment

1,410

Participants

Timeline

Start Date

January 25, 2021

Primary Completion Date

November 20, 2021

Study Completion Date

October 20, 2022

Conditions
Heart Failure With Reduced Ejection Fraction
Interventions
OTHER

Best practice alert for the notification of patient HFrEF and recommended evidence-based therapies (NO drugs are being administered in this trial)

Providers will receive a best practice alert for each of their eligible patients upon opening of the order entry screen in the patient's medical record. The alert will inform the provider to the presence of HFrEF and of the patient's current left ventricular ejection fraction and current evidence-based medications for HFrEF. It will also provide access to an order set with recommended evidence-based HFrEF therapies as well as a link to the best available guideline-recommended information regarding the treatment of heart failure.

Trial Locations (1)

06510

Yale New Haven Health System selected outpatient clinics, New Haven

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

AstraZeneca

INDUSTRY

lead

Yale University

OTHER